Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Patterson Companies    PDCO

PATTERSON COMPANIES (PDCO)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

PATTERSON : Companies 3rd Quarter Fiscal 2011 Conference Call Scheduled for February 24

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/10/2011 | 02:35pm CEST

Patterson Companies (Nasdaq: PDCO) today announced that it will hold its conference call to review operating results for the third quarter of fiscal 2011 on Thursday, February 24 at 10:00 AM Eastern. The Patterson earnings release will be issued before the market opens that day.

Investors can access a live webcast of the conference call by visiting the investor relations section of the Patterson Companies website, www.PattersonCompanies.com. The webcast will be archived on Patterson's website. Following the conference call, a replay will be available for one week. Interested persons may dial 303-590-3030 and provide the Conference ID, 4411978, when prompted.

About Patterson Companies, Inc.
Patterson Companies, Inc. is a value-added distributor serving the dental, companion-pet veterinarian and rehabilitation supply markets.
Dental Market
As Patterson's largest business, Patterson Dental provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions and value-added services to dentists and dental laboratories throughout North America.
Veterinary Market
Webster Veterinary is the nation's second largest distributor of consumable veterinary supplies, equipment and software, diagnostic products, vaccines and pharmaceuticals to companion-pet veterinary clinics.
Rehabilitation Market
Patterson Medical is the world's leading distributor of rehabilitation supplies and non-wheelchair assistive patient products to the physical and occupational therapy markets. The unit's global customer base includes hospitals, long-term care facilities, clinics and dealers.

Patterson Companies
R. Stephen Armstrong
Executive Vice President & CFO
651-686-1600
or
Equity Market Partners
Richard G. Cinquina
904-415-1415


© Business Wire 2011
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PATTERSON COMPANIES
07:13pSTANDALONE VETERINARY IMAGING SOFTWA : Top Key Vendors in Market: Henry Schein (..
AQ
03:15pPATTERSON COMPANIES, INC. : annual earnings release
06/13PATTERSON : EPS for Patterson Companies, Inc. (PDCO) Expected At $0.31
AQ
06/12PATTERSON COMPANIES, INC. : Change in Directors or Principal Officers, Financial..
AQ
06/12PATTERSON : Elects Francis J. Malecha to Board of Directors
BU
06/12PATTERSON : Declares Regular Quarterly Cash Dividend
BU
05/31PATTERSON : Fourth-Quarter Fiscal 2018 Conference Call Scheduled for Thursday, J..
BU
05/30VETERINARY PRACTICE MANAGEMENT SOFTW : IDEXX Laboratories, Henry Schein, Patters..
AQ
05/29PATTERSON COMPANIES : DEADLINE TODAY: Levi & Korsinsky, LLP Reminds Shareholders..
AC
05/29PATTERSON COMPANIES : FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC ..
AC
More news
News from SeekingAlpha
06/12Patterson declares $0.26 dividend 
05/24TOP WALL STREET HEALTHCARE GAINERS F : Allergan, CVS Health, Patterson, Sanofi, .. 
05/23Patterson Companies announces leadership team additions 
04/25Henry Schein - What Buffett Would Call A Wonderful Company At A Fair Price 
04/24BY THE NUMBERS : Healthcare Stocks With Big Cash Distributions 
Financials ($)
Sales 2018 5 489 M
EBIT 2018 265 M
Net income 2018 199 M
Debt 2018 985 M
Yield 2018 4,79%
P/E ratio 2018 10,73
P/E ratio 2019 14,70
EV / Sales 2018 0,57x
EV / Sales 2019 0,55x
Capitalization 2 118 M
Chart PATTERSON COMPANIES
Duration : Period :
Patterson Companies Technical Analysis Chart | PDCO | US7033951036 | 4-Traders
Technical analysis trends PATTERSON COMPANIES
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Average target price 24,1 $
Spread / Average Target 7,9%
EPS Revisions
Managers
NameTitle
Mark Walchirk President, Chief Executive Officer & Director
John Dean Buck Chairman
Dennis W. Goedken Chief Financial Officer, Treasurer & Controller
Dave Lardy Chief Information Officer
James W. Wiltz Director
Sector and Competitors
1st jan.Capitalization (M$)
PATTERSON COMPANIES-38.06%2 118
COLOPLAST A/S28.67%19 597
HENRY SCHEIN4.88%11 288
AMPLIFON SPA34.11%4 525
CANTEL MEDICAL CORP.-2.78%4 172
MERIT MEDICAL SYSTEMS, INC.16.09%2 528